Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-30

Clinical Trial Update: Rapid Agitation Control With Ketamine in the Emergency Department [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rapid agitation control with ketamine in the emergency department has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: David Barbic | Conditions: Violent Aggressive Behavior, Ketamine | Phase 2 | Status: COMPLETED